| Purvi Amin, RPH | |
|
31700 Grape St, Lake Elsinore, CA 92532-9785 | |
| (951) 245-4329 | |
| Not Available |
| Full Name | Purvi Amin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 31700 Grape St, Lake Elsinore, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427467794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH51644 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Purvi Amin, RPH 31700 Grape St, Lake Elsinore, CA 92532-9785 Ph: (951) 245-4329 | Purvi Amin, RPH 31700 Grape St, Lake Elsinore, CA 92532-9785 Ph: (951) 245-4329 |
News Archive
Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.
A new study has found that chlorophyll and its derivative chlorophyllin are effective in limiting the absorption of aflatoxin in humans. Aflatoxin is produced by a fungus that is a contaminant of grains including corn, peanuts and soybeans; it is known to cause liver cancer - and can work in concert with other health concerns, such as hepatitis.
Boehringer Ingelheim will present results from LUX-Lung 3, the company's pivotal Phase III clinical trial investigating afatinib in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation (EGFR M+), at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012.
ChemGenex Pharmaceuticals Limited announced today that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.
The Johns Hopkins University, the Johns Hopkins University School of Medicine, Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine in Baltimore, USA, and Academic Medical Centre Sdn Bhd, subsidiary of Chase Perdana Sdn Bhd, a Kuala Lumpur-based private development corporation, and an associate company of Turiya Sdn Bhd, have signed an agreement to help Malaysia develop its first fully integrated private four-year graduate medical school and teaching hospital.
› Verified 2 days ago
Carlos Leslie Saenz, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29315 Central Ave, Lake Elsinore, CA 92532 Phone: 951-253-6039 | |
Amanda Sophie Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 Diamond Dr, Lake Elsinore, CA 92530 Phone: 951-674-3562 | |
Michelle Oei, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2091 E Lakeshore Dr, Lake Elsinore, CA 92530 Phone: 951-245-5540 | |
Dr. Joe Anigbogu, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29260 Central Ave, Lake Elsinore, CA 92532 Phone: 951-245-4329 | |
Alfred Metwashla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18269 Collier Ave, Lake Elsinore, CA 92530 Phone: 760-670-9463 | |
Lena Nam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29985 Canyon Hills Rd, Lake Elsinore, CA 92532 Phone: 951-244-6001 Fax: 951-244-2116 | |
Mr. Christopher Yeong-shyang Liu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31700 Grape St, Lake Elsinore, CA 92532 Phone: 951-245-4329 |